Average Price Target: $10.00
▲ +79.86% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for IM Cannabis in the last 3 months. The average price target is $10.00, with a high forecast of $10.00 and a low forecast of $10.00. The average price target represents a 79.86% upside from the last price of $5.56.
The current consensus among 1 contributing investment analysts is to buy stock in IM Cannabis.
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers strains under the Roma, Dairy Queen, London, Tel Aviv, Paris, and Pandora Box brands; and CBD oil products under the IMC brand. The company also offers its intellectual property related services to the medical cannabis industry. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.